Experimental Drug Inhibits or Prevents Diabetic Eye Disease in Wilmer Eye Institute Study

2024-02-27 07:52:42

Artistic rendition of diabetic eye disease highlighting vascular changes (i.e., retinal neovascularization) observed in patients with proliferative diabetic retinopathy. Credit: Isabella S. Sodhi, McDonogh School

News from our full member the Wilmer Eye Institute – Johns Hopkins

Research from Akrit Sodhi and colleagues shows that an experimental drug may prevent or slow vision loss in people with diabetes.

More information here!

Source and image: Wilmer Eye Institute – Johns Hopkins

More news

Introduction to Orbis and the Flying Eye Hospital

Orbis is a leading global non-governmental organization that has worked to transform lives through the prevention and treatment of blindness for over 35 years. With our network of partners, we […]

New Member of the WAEH

The board of the WAEH wants to wish the Magrabi Eye Hospital a warm welcome. The World Association of Eye Hospitals is a worldwide network of eye hospitals and is […]

New Member of the WAEH

The board of the WAEH wants to wish OrBis the Flying Eye Hospital a warm welcome. The World Association of Eye Hospitals is a worldwide network of eye hospitals and […]

Newsletter April 2019

WAEH 2019? Access to knowledge about eyehospitals worldwide and learn about the latest trends in innovation, artifical intelligence, education, different models of eyecare and safety from top level international eye […]

World’s first clinical trial of a robot in routine vitreoretinal eye surgery begins: Preceyes’ robotic assistant used for ERM peels at Rotterdam Eye Hospital

Eindhoven, 15 May 2019 Precision and accuracy are precisely what’s needed when eye surgeons perform a procedure called an epiretinal membrane (ERM) peel. And a Dutch robotics company, Preceyes (Eindhoven, […]